|
1) Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999; 285: 110-3
|
|
|
|
2) Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005; 11: 791-6
|
|
|
|
|
|
3) Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001; 7: 927-33
|
|
|
|
|
|
4) Elmowalid GA, Qiao M, Jeong SH, et al. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci USA. 2007; 104: 8427-32
|
|
|
|
|
|
5) Folgori A, Capone S, Ruggeri L, et al. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med. 2006; 12: 190-7
|
|
|
|
|
|
6) Lindenbach BD, Meuleman P, Ploss A, et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA. 2006; 103: 3805-9
|
|
|
|
|
|
7) Walter E, Keist R, Niederost B, et al. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology. 1996; 24: 1-5
|
|
|
|
|
|
8) Xie ZC, Riezu-Boj JI, Lasarte JJ, et al. Transmission of hepatitis C virus infection to tree shrews. Virology. 1998; 244: 513-20
|
|
|
|
|
|
9) Scarselli E, Urbani A, Sbardellati A, et al. GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity. J Virol. 1997; 71: 4985-9
|
|
|
|
|
|
10) Butkiewicz N, Yao N, Zhong W, et al. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol. 2000; 74: 4291-301
|
|
|
|
|
|
11) Kneteman NM, Weiner AJ, O'Connell J, et al. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology. 2006; 43: 1346-53
|
|
|
|
|
|
12) Inoue K, Umehara T, Ruegg UT, et al. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology. 2007; 45: 921-8
|
|
|
|
|
|
13) Nakagawa S, Umehara T, Matsuda C, et al. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem Biophys Res Commun. 2007; 353: 882-8
|
|
|
|
|
|
14) Walters KA, Joyce MA, Thompson JC, et al. Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog. 2006; 2: e59
|
|
|
|
|
|
15) Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA. 1997; 94: 233-6
|
|
|
|
|
|
16) Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol. 1997; 78: 1527-31
|
|
|
|
|
|
17) Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998; 4: 1065-7
|
|
|
|
|
|
18) Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001; 61: 4365-70
|
|
|
|
|
|
19) Korenaga M, Wang T, Li Y, et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem. 2005; 280: 37481-8
|
|
|
|
|
|
20) Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004; 126: 840-8
|
|
|
|
|
|
21) Moriishi K, Mochizuki R, Moriya K, et al. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA. 2007; 104: 1661-6
|
|
|
|
|
|
22) Miyamoto H, Moriishi K, Moriya K, et al. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol. 2007; 81: 1727-35
|
|
|
|
|